Richard Prins's Insider Trades & SAST Disclosures
Richard Prins's most recent trade in Amphastar Pharmaceuticals Inc was a trade of 10,000 Common Stock done at an average price of $19.5 . Disclosure was reported to the exchange on Dec. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard Prins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.52 per share. | 09 Dec 2024 | 10,000 | 40,471 (0%) | 0% | 19.5 | 195,200 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 43.77 per share. | 09 Dec 2024 | 10,000 | 30,471 (0%) | 0% | 43.8 | 437,702 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2024 | 410 | 30,061 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 48.80 per share. | 12 Nov 2024 | 5,000 | 31,471 (0%) | 0% | 48.8 | 243,986 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.69 per share. | 12 Nov 2024 | 2,500 | 36,471 (0%) | 0% | 16.7 | 41,725 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 2,500 | 4,179 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 1,000 | 30,471 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 43.07 per share. | 12 Aug 2024 | 17,101 | 33,971 (0%) | 0% | 43.1 | 736,550 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 7,182 | 10,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.52 per share. | 12 Aug 2024 | 7,182 | 51,072 (0%) | 0% | 19.5 | 140,193 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 6,004 | 10,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.08 per share. | 12 Aug 2024 | 6,004 | 43,890 (0%) | 0% | 20.1 | 120,560 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.03 per share. | 12 Aug 2024 | 3,915 | 37,886 (0%) | 0% | 20.0 | 78,417 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 3,915 | 10,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 6,864 | 6,864 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 3,076 | 33,971 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 18 Aug 2023 | 2,000 | 40,895 (0%) | 0% | 52.5 | 105,006 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 57.39 per share. | 15 Aug 2023 | 4,163 | 42,895 (0%) | 0% | 57.4 | 238,911 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 7,016 | 7,016 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 2,716 | 47,058 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 5,000 | 6,679 | - | - | Stock option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 5,000 | 11 | - | - | Stock option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 12 May 2023 | 5,000 | 44,342 (0%) | 0% | 43.5 | 217,502 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.69 per share. | 12 May 2023 | 5,000 | 49,342 (0%) | 0% | 16.7 | 83,450 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 42.06 per share. | 12 May 2023 | 5,000 | 47,342 (0%) | 0% | 42.1 | 210,323 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.69 per share. | 12 May 2023 | 5,000 | 52,342 (0%) | 0% | 16.7 | 83,450 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2023 | 3,000 | 44,342 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,163 | 47,342 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2022 | 2,000 | 43,179 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 15 Mar 2022 | 10,000 | 55,179 (0%) | 0% | 17.1 | 171,100 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 15 Mar 2022 | 10,000 | 45,179 (0%) | 0% | 34.0 | 340,208 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 21.36 per share. | 10 Dec 2021 | 5,291 | 45,179 (0%) | 0% | 21.4 | 113,006 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 5,291 | 10,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 10 Dec 2021 | 5,291 | 50,470 (0%) | 0% | 17.1 | 90,529 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 22 Nov 2021 | 5,000 | 50,179 (0%) | 0% | 17.1 | 85,550 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 5,000 | 15,291 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 21.22 per share. | 22 Nov 2021 | 5,000 | 45,179 (0%) | 0% | 21.2 | 106,100 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,182 | 17,182 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 6,019 | 45,179 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 04 Jun 2021 | 5,000 | 39,160 (0%) | 0% | 18.8 | 93,851 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 04 Jun 2021 | 5,000 | 44,160 (0%) | 0% | 16.4 | 82,150 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 18.70 per share. | 04 Jun 2021 | 5,000 | 39,160 (0%) | 0% | 18.7 | 93,500 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 04 Jun 2021 | 5,000 | 44,160 (0%) | 0% | 16.4 | 82,150 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 11 May 2021 | 15,827 | 54,987 (0%) | 0% | 16.4 | 260,038 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 15,827 | 10,000 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 18.90 per share. | 11 May 2021 | 15,827 | 39,160 (0%) | 0% | 18.9 | 299,110 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 11 Aug 2020 | 6,000 | 39,160 (0%) | 0% | 20.3 | 121,976 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 16,004 | 16,004 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 5,851 | 45,160 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.11 per share. | 12 May 2020 | 30,282 | 69,591 (0%) | 0% | 15.1 | 457,561 | Common Stock |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2020 | 30,282 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Richard Prins | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 12 May 2020 | 30,282 | 39,309 (0%) | 0% | 19.0 | 575,419 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges